Yahoo! Finance: VRUS NewsLatest Financial News for PHARMASSET INC.Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C (PR Newswire)- August 5, 2008 Pharmasset, Inc. announces the preliminary results of the third cohort of a 4-week Phase 1 clinical trial evaluating R7128 1000mg twice daily in combination with the standard of care , Pegasys plus Copegus , in 31 treatment-naive patients chronically infected with hepatitis C virus genotype 1.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080805/cltu041.... Vertex on the Verge of Victory (at Motley Fool)- August 4, 2008http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12q8797m8/*http://www.fool.com/inves... |